Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 8 of 8 entries
Sorted by: Best Match Show Resources per page
Bibliography. Current world literature. Cystic fibrosis.

Current opinion in pulmonary medicine

[No authors listed]
PMID: 15599968
Curr Opin Pulm Med. 2004 Nov;10(6):561-7.

No abstract available.

Cite
Bibliography. Current world literature. Cystic fibrosis. Curr Opin Pulm Med. 2004;10(6):561-7
(2004). Bibliography. Current world literature. Cystic fibrosis. Current opinion in pulmonary medicine, 10(6), 561-7.
"Bibliography. Current world literature. Cystic fibrosis." Current opinion in pulmonary medicine vol. 10,6 (2004): 561-7.
Bibliography. Current world literature. Cystic fibrosis. Curr Opin Pulm Med. 2004 Nov;10(6):561-7. PMID: 15599968.
Copy Download .nbib Format: NLM
Collaboration may be the cure for what ails drug development.

Nature medicine

Erickson AK.
PMID: 15170189
Nat Med. 2004 Jun;10(6):558. doi: 10.1038/nm0604-558b.

No abstract available.

Cite
Erickson AK. Collaboration may be the cure for what ails drug development. Nat Med. 2004;10(6):558doi: 10.1038/nm0604-558b.
Erickson, A. K. (2004). Collaboration may be the cure for what ails drug development. Nature medicine, 10(6), 558. https://doi.org/10.1038/nm0604-558b
Erickson, Amy K. "Collaboration may be the cure for what ails drug development." Nature medicine vol. 10,6 (2004): 558. doi: https://doi.org/10.1038/nm0604-558b
Erickson AK. Collaboration may be the cure for what ails drug development. Nat Med. 2004 Jun;10(6):558. doi: 10.1038/nm0604-558b. PMID: 15170189.
Copy Download .nbib Format: NLM
A review of renal disease in cystic fibrosis.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Nazareth D, Walshaw M.
PMID: 23618617
J Cyst Fibros. 2013 Jul;12(4):309-17. doi: 10.1016/j.jcf.2013.03.005. Epub 2013 Apr 22.

Kidney disease is becoming increasingly common in CF. This review looks at the effect of CFTR on the kidney, the problems with measuring renal function effectively in CF, the causes and incidence of renal dysfunction, and its pathophysiology. Strategies...

Cite
Nazareth D, Walshaw M. A review of renal disease in cystic fibrosis. J Cyst Fibros. 2013;12(4):309-17doi: 10.1016/j.jcf.2013.03.005.
Nazareth, D., & Walshaw, M. (2013). A review of renal disease in cystic fibrosis. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 12(4), 309-17. https://doi.org/10.1016/j.jcf.2013.03.005
Nazareth, Dilip, and Walshaw, Martin. "A review of renal disease in cystic fibrosis." Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society vol. 12,4 (2013): 309-17. doi: https://doi.org/10.1016/j.jcf.2013.03.005
Nazareth D, Walshaw M. A review of renal disease in cystic fibrosis. J Cyst Fibros. 2013 Jul;12(4):309-17. doi: 10.1016/j.jcf.2013.03.005. Epub 2013 Apr 22. PMID: 23618617.
Copy Download .nbib Format: NLM
Cystic fibrosis.

Current opinion in pulmonary medicine

Marshall BC.
PMID: 14534399
Curr Opin Pulm Med. 2003 Nov;9(6):484-5. doi: 10.1097/00063198-200311000-00006.

No abstract available.

Cite
Marshall BC. Cystic fibrosis. Curr Opin Pulm Med. 2003;9(6):484-5doi: 10.1097/00063198-200311000-00006.
Marshall, B. C. (2003). Cystic fibrosis. Current opinion in pulmonary medicine, 9(6), 484-5. https://doi.org/10.1097/00063198-200311000-00006
Marshall, Bruce C. "Cystic fibrosis." Current opinion in pulmonary medicine vol. 9,6 (2003): 484-5. doi: https://doi.org/10.1097/00063198-200311000-00006
Marshall BC. Cystic fibrosis. Curr Opin Pulm Med. 2003 Nov;9(6):484-5. doi: 10.1097/00063198-200311000-00006. PMID: 14534399.
Copy Download .nbib Format: NLM
[Novel therapies for cystic fibrosis in 2009].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie

Sermet-Gaudelus I, Le Bourgeois M, Edelman A, Lenoir G.
PMID: 19541091
Arch Pediatr. 2009 Jun;16(6):578-80. doi: 10.1016/S0929-693X(09)74073-4.

No abstract available.

Cite
Sermet-Gaudelus I, Le Bourgeois M, Edelman A, et al. Nouvelles thérapies dans la mucoviscidose en 2009. [Novel therapies for cystic fibrosis in 2009]. Arch Pediatr. 2009;16(6):578-80doi: 10.1016/S0929-693X(09)74073-4.
Sermet-Gaudelus, I., Le Bourgeois, M., Edelman, A., & Lenoir, G. (2009). Nouvelles thérapies dans la mucoviscidose en 2009. [Novel therapies for cystic fibrosis in 2009]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 16(6), 578-80. https://doi.org/10.1016/S0929-693X(09)74073-4
Sermet-Gaudelus, I, et al. "Nouvelles thérapies dans la mucoviscidose en 2009." [Novel therapies for cystic fibrosis in 2009]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie vol. 16,6 (2009): 578-80. doi: https://doi.org/10.1016/S0929-693X(09)74073-4
Sermet-Gaudelus I, Le Bourgeois M, Edelman A, Lenoir G. Nouvelles thérapies dans la mucoviscidose en 2009. [Novel therapies for cystic fibrosis in 2009]. Arch Pediatr. 2009 Jun;16(6):578-80. doi: 10.1016/S0929-693X(09)74073-4. French. PMID: 19541091.
Copy Download .nbib Format: NLM
A milestone.

Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation

Gutekunst L.
PMID: 22520616
J Ren Nutr. 2012 May;22(3):377. doi: 10.1053/j.jrn.2012.02.004.

No abstract available.

Cite
Gutekunst L. A milestone. J Ren Nutr. 2012;22(3):377doi: 10.1053/j.jrn.2012.02.004.
Gutekunst, L. (2012). A milestone. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation, 22(3), 377. https://doi.org/10.1053/j.jrn.2012.02.004
Gutekunst, Lisa. "A milestone." Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation vol. 22,3 (2012): 377. doi: https://doi.org/10.1053/j.jrn.2012.02.004
Gutekunst L. A milestone. J Ren Nutr. 2012 May;22(3):377. doi: 10.1053/j.jrn.2012.02.004. PMID: 22520616.
Copy Download .nbib Format: NLM
Disease-Specific Clinical Trial Networks: the Example of Cystic Fibrosis.

Drug research

van Koningsbruggen-Rietschel S.
PMID: 30453371
Drug Res (Stuttg). 2018 Nov;68:S21-S23. doi: 10.1055/a-0733-0883. Epub 2018 Nov 19.

No abstract available.

Cite
van Koningsbruggen-Rietschel S. Disease-Specific Clinical Trial Networks: the Example of Cystic Fibrosis. Drug Res (Stuttg). 2018;68:S21-S23doi: 10.1055/a-0733-0883.
van Koningsbruggen-Rietschel, S. (2018). Disease-Specific Clinical Trial Networks: the Example of Cystic Fibrosis. Drug research, 68S21-S23. https://doi.org/10.1055/a-0733-0883
van Koningsbruggen-Rietschel, Silke. "Disease-Specific Clinical Trial Networks: the Example of Cystic Fibrosis." Drug research vol. 68 (2018): S21-S23. doi: https://doi.org/10.1055/a-0733-0883
van Koningsbruggen-Rietschel S. Disease-Specific Clinical Trial Networks: the Example of Cystic Fibrosis. Drug Res (Stuttg). 2018 Nov;68:S21-S23. doi: 10.1055/a-0733-0883. Epub 2018 Nov 19. PMID: 30453371.
Copy Download .nbib Format: NLM
Prevention of drug-related complications in cystic fibrosis.

Current opinion in pulmonary medicine

van der Meer R, Touw DJ, Heijerman HGM.
PMID: 31503211
Curr Opin Pulm Med. 2019 Nov;25(6):666-673. doi: 10.1097/MCP.0000000000000625.

PURPOSE OF REVIEW: Due to continuous development of new drugs and better treatment strategies, survival of patients with cystic fibrosis has changed dramatically. Recently, targeted therapy of cystic fibrosis transmembrane conductance regulator (CFTR) modulators have become available. Despite these...

Cite
van der Meer R, Touw DJ, Heijerman HGM. Prevention of drug-related complications in cystic fibrosis. Curr Opin Pulm Med. 2019;25(6):666-673doi: 10.1097/MCP.0000000000000625.
van der Meer, R., Touw, D. J., & Heijerman, H. G. M. (2019). Prevention of drug-related complications in cystic fibrosis. Current opinion in pulmonary medicine, 25(6), 666-673. https://doi.org/10.1097/MCP.0000000000000625
van der Meer, Renske, et al. "Prevention of drug-related complications in cystic fibrosis." Current opinion in pulmonary medicine vol. 25,6 (2019): 666-673. doi: https://doi.org/10.1097/MCP.0000000000000625
van der Meer R, Touw DJ, Heijerman HGM. Prevention of drug-related complications in cystic fibrosis. Curr Opin Pulm Med. 2019 Nov;25(6):666-673. doi: 10.1097/MCP.0000000000000625. PMID: 31503211.
Copy Download .nbib Format: NLM
Showing 1 to 8 of 8 entries